NCT06559007 2025-03-18
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
Atridia Pty Ltd.
Phase 1 Completed
Atridia Pty Ltd.
The Third Affiliated hospital of Zhejiang Chinese Medical University
The First Affiliated Hospital with Nanjing Medical University
Nobelpharma